Interim results for a novel DNA plasmid BHT-3021 from a phase I/II type 1 diabetes study Sep. 23, 2008
Takeda to initiate Japanese phase III trial of cetilistat and pay milestone payment to Alizyme Sep. 22, 2008
RSS